AMPA Receptor-Positive Allosteric Modulators for the Treatment of Schizophrenia: An Overview of Recent Patent Applications
- 1 March 2015
- journal article
- review article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 7 (4) , 473-491
Abstract
The role of glutamate and its receptors in central nervous system biology and disease has long been of interest to scientists involved in both fundamental research and drug discovery, however the complex pharmacology and lack of highly selective compounds has severely hampered drug discovery efforts in this area. Recent advances in the identification and profiling of positive allosteric modulators of the AMPA receptor offer a potential way forward and the hope of a new treatment for schizophrenia. This article will review recent patent applications published in this area.Keywords
This publication has 62 references indexed in Scilit:
- Emerging Models of Glutamate Receptor Ion Channel Structure and FunctionStructure, 2011
- Structure and mechanism of glutamate receptor ion channel assembly, activation and modulationCurrent Opinion in Neurobiology, 2011
- Contribution of the Global Subunit Structure and Stargazin on the Maturation of AMPA ReceptorsJournal of Neuroscience, 2010
- X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptorNature, 2009
- A nomenclature for ligand-gated ion channelsNeuropharmacology, 2009
- Pharmacological insights obtained from structure–function studies of ionotropic glutamate receptorsBritish Journal of Pharmacology, 2006
- Ionotropic and metabotropic glutamate receptor structure and pharmacologyPsychopharmacology, 2005
- Expression of transcripts encoding AMPA receptor subunits and associated postsynaptic proteins in the macaque brainJournal of Comparative Neurology, 2003
- Molecular Cloning and Functional Expression of Glutamate Receptor Subunit GenesScience, 1990
- A Family of AMPA-Selective Glutamate ReceptorsScience, 1990